Recruiting CEBPA to the promoter of PLK2 negatively regulates its expression.40 Therefore, like its role in acute myeloid leukemia, CEBPA is recognized as an antitumor TF in osteosarcoma. The gene discussed is CEBPA; the disease is acute myeloid leukemia.